Science & Medicine

Zebra Coalition Post



Subject: FDA:  Require a Patient Advocate in Clinical Trial


The Zebra Coalition created a petition to Dr. Margaret A. Hamburg, Commissioner, Food and Drug Administration, The United States House of Representatives, and The United States Senate which says:

“We ask that the FDA require a Patient Advocate be available at every Investigative New Drug clinical trial site to provide a needed level of Patient safety. The Patient Advocate would be informed —  along with site Investigators —  of every Severe Adverse Event (SAE) occurring in the course of the trial.

The Patient Advocate  would be empowered to communicate directly with Patients and with Investigators on behalf of Patients.   ”

Will you sign this petition? Click here:


Comments on: "Zebra Coalition Post" (2)

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: